The impact of COVID-19 on hypertensive patients and multiprofessional performance: an integrative review
DOI:
https://doi.org/10.33448/rsd-v12i4.40985Keywords:
Hypertension; COVID-19; Chronic Disease; Multiprofessional.Abstract
Objective: to describe the factors that impact the progression and severity of coronavirus infection in hypertensive patients, as well as identify coping actions that control this morbidity. Methodology: An integrative review of publications available in the MEDLINE, LILACS and SciELO databases was carried out from June to July 2021. The search terms used were: “Hypertension” AND “COVID-19” AND “Chronic Disease”. Results: Eight articles were identified and included for the review. The factors addressed were categorized into three groups of common issues: Immunological factors; Antihypertensive therapy and Social and public health factors. The main impacts include lymphocytopenias, severe pneumonias and lethal growth. Conclusion: Hypertensive patients are negatively impacted by the COVID-19 pandemic, with important reactions and increased mortality. However, the literature still presents disagreements about the real factors that contribute to a worse clinical outcome.
References
Albuquerque, A. C. B., Albuquerque, J. B., Gomes, V. M. D. O., Martins, D. R., & Watanabe, A. S. A. (2021). A Tempestade De Citocinas Na Covid-19: Uma Revisão Narrativa. Revista Multidisciplinar em Saúde. 2(2), 23-23.
Alcocer-Díaz-Barreiro, L., Cossio-Aranda, J., Verdejo-Paris, J., Ríos, M. O. D. L., Galván-Oseguera, H., Álvarez-López, H., & Alcocer-Gamba, M. A. (2020). COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship. Archivos de cardiologia de Mexico. 90, 19-25.
Asturian, K. (2021). O papel dos inibidores da enzima conversora de angiotensina e dos antagonistas dos receptores de angiotensina em pacientes com Covid-19: uma revisão narrativa. Revista de Ciências Médicas. 30(1), 1-7.
Barros, G. M., Mazullo Filho, J. B. R., & Júnior, A. C. M. (2020). Considerações sobre a relação entre a hipertensão e o prognóstico da COVID-19. Journal of Health & Biological Sciences. 8, (1), 1-3.
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., ... & Nadruz, W. (2020). Diretrizes Brasileiras de Hipertensão Arterial–2020. Arquivos Brasileiros de Cardiologia. 116 (3), 516-658.
Bezerra, A. C. V., Silva, C. E. M. D., Soares, F. R. G., & Silva, J. A. M. D. (2020). Factors associated with people's behavior in social isolation during the COVID-19 pandemic. Ciencia & saude coletiva. 25, 2411-2421.
Beyea SC, Nicoll LH. (1998). Writing an integrative review. AORN J. 67(4), 877-80.
Botelho, L. L. R., de Almeida Cunha, C. C., & Macedo, M. (2011). O método da revisão integrativa nos estudos organizacionais. Gestão e sociedade, 5(11), 121-136.
Bress, A. P., Cohen, J. B., Anstey, D. E., Conroy, M. B., Ferdinand, K. C., Fontil, V., ... & Mohanty, A. F. (2021). Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID‐19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID‐19 Pandemic. Journal of American Heart Association. 10(11), 020997.
Calzerra, N. T. M., Gomes, C. F., & De Queiroz, T. M. (2018). Aspectos fisiopatológicos da hipertensão arterial dependente de angiotensina II: revisão integrada da literatura. Acta Brasiliensis, 2(2), 69-73.
Cunha, T. G. S., Guimarães, A. D. S. M., dos Santos, T. A., & de Vasconcelos Freire, L. B. (2020). Atuação da equipe multiprofissional em saúde, no cenário da pandemia por Covid 19. Health Residencies Journal-HRJ. 1(2), 1-22.
Drager, L. F., Pio-Abreu, A., Lopes, R. D., & Bortolotto, L. A. (2020). Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic?. Current hypertension reports. 22(6), 1-6.
Flores-Soto, E., & Ramírez, L. M. M. (2020). COVID-19 y su asociación con los inhibidores de la enzima convertidora de angiotensina y los antagonistas de los receptores para angiotensina II. Revista de la Facultad de Medicina UNAM. 63(4), 30-34.
Ganong LH. (1987). Integrative reviews of nursing research. Res Nurs Health. 10(1), 1-11.
Gao, C., Cai, Y., Zhang, K., Zhou, L., Zhang, Y., Zhang, X., ... & Li, F. (2020). Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. European heart jornal. 41(22), 2058-2066.
Golpe, R., Pérez-de-Llano, L. A., Dacal, D., Guerrero-Sande, H., Pombo-Vide, B., & Ventura-Valcárcel, P. (2020). Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors. Medicina clinica. 155(11), 488-490.
Hu, B., Huang, S., & Yin, L. (2021). The cytokine storm and COVID‐19. Journal of medical virology. 93(1), 250-256.
Leitão, V. B. G., Lemos, V. C., Francisco, P. M. S. B., & Costa, K. S. (2020). Prevalência de uso e fontes de obtenção de medicamentos anti-hipertensivos no Brasil: análise do inquérito telefônico VIGITEL. Revista Brasileira de Epidemiologia. 23(1), 1-14.
Magrini, D. W., & Martini, J. G. (2021). Hipertensão arterial: principais fatores de risco modificáveis na estratégia saúde da família. Enfermeria global. 11(2), 344-352.
Medina G, Giovanella, L., Bousquat, A., Mendonça, M. H.M., Aquino, R. (2020). Primary healthcare in times of COVID-19: what to do? Cadernos de Saude Publica. 36(8), 1-5.
Melo, D. O. D., Ribeiro, T. B., Grezzana, G. B., & Stein, A. T. (2020). COVID-19 e doença hipertensiva no Brasil: Possibilidae de uma tempestade perfeita. Rev. Bras. Epidemiol. 23, 1-4.
Nashiry, A., Sarmin Sumi, S., Islam, S., Quinn, J. M., & Moni, M. A. (2021). Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities. Briefings in bioinformatics. 22(2), 1387-1401.
Oliveira, M., Sousa, P., Sousa, L., Mendes, C., Labucha, M., & Macedo, F.A. (2020). Cardiologia na Pandemia COVID-19: Que Impacto na Atividade Clínica? Cardiology in the Pandemic COVID-19: What is the Impact in Clinical Activity?. Gazeta Médica. 2(7), 101-106.
Pérez-Sastré, M. A., Valdés, J., & Ortiz-Hernández, L. (2020). Características clínicas y gravedad de COVID-19 en adultos mexicanos. Gaceta médica de México. 156(5), 379-387.
Salazar, M., Barochiner, J., Espeche, W., & Ennis, I. (2020). COVID-19, hipertensión y enfermedad cardiovascular. Hipertensión y riesgo vascular. 37(4), 176-180.
Sampaio, S. M. L., Silva, I. B., de Luna, C. A., Rangel, J. F., Feitosa, P. G., Ferreira, F. D. W., ... & Teixeira, A. N. N. (2021). Promoção da saúde de pacientes hipertensos: uma revisão integrativa. Brazilian Journal of Health Review. 4(2), 5238-5249.
Silva MS, Pinheiro FSG, Higino KLS, Santos AP, Santos RL. (2020). Evidências científicas clínicas entre o novo Coronavírus e a hipertensão arterial: uma revisão integrativa. J. nurs. health. 10(4), 2-10.
Sousa, M. T., do Amparo Santos, M., dos Santos Pereira, I., da Fonseca, H. A. T., Pereira, M. L., das Virgens, C. M. B., ... & de Queiroz Carvalho, F. L. (2021). Ações educativas: dieta, atividade física e suas possíveis influências sobre a pressão arterial. Brazilian Journal of Development. 7(1), 226-242.
Souza Santos, J. F., Domingues, A. N., Mendes, A. A., Tognoli, S. H., Ogata, M. N., & Binotto, C. C. S. (2020). Atendimento de hipertensão arterial sistêmica na estratégia saúde da família: sob a ótica de enfermeiros e agentes comunitários de saúde. Revista Brasileira Multidisciplinar. 23(2Supl.), 90-98.
Xia, F., Zhang, M., Cui, B., An, W., Chen, M., Yang, P., ... & Zhang, J. (2021). COVID-19 patients with hypertension are at potential risk of worsened organ injury. Scientific Reports. 11(1), 1-10.
Xiong, T. Y., Huang, F. Y., Liu, Q., Peng, Y., Xu, Y. N., Wei, J. F., ... & Chen, M. (2020). Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study. Annals of medicine. 52(7), 361-366.
Yang, Q., Zhou, Y., Wang, X., Gao, S., Xiao, Y., Zhang, W., ... & Wang, Y. (2020). Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score–matching analysis. Respiratory research. 21(1), 1-9.
Zeng, Q., Li, Y. Z., Dong, S. Y., Chen, Z. T., Gao, X. Y., Zhang, H., ... & Xu, Y. (2020). Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Frontiers in immunology. 11, 1-9.
Zeng, Z., Sha, T., Zhang, Y., Wu, F., Hu, H., Li, H., ... & Chen, Z. (2020). Hypertension in Patients Hospitalized with COVID-19 in Wuhan, China A Single-Center Retrospective Observational Study. International Heart Journal. 62(2), 337-343.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Marceli Dias Ferreira; Lúcia Aparecida Lebioda Camilo; Larissa Knysak Ranthum; Alessandro Otávio Silton Savi; Paula Renata Barbosa Laroca; Erildo Vicente Muller; Pollyanna Kássia de Oliveira Borges
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
